FBR’s Healthcare Research group is differentiated in part given its many years of experience, providing the team an advantage in offering unique industry and company-specific insights that help our clients reach their investment goals.
Our healthcare team includes a group of highly experienced individuals who have each followed their respective industries for nearly 20 years. In turn, they are well positioned to uniquely recognize key fundamental trends, offer in-depth analysis, and most importantly, identify opportunities and risks. While we also maintain a disciplined, valuation-driven approach to stock-picking, broad industry contacts help our team understand investor perspectives. Our coverage includes a growing array of companies across various subsectors and market-caps, including the following specialties:
- Healthcare Distribution
- Healthcare Facilities - Clinical Labs
- Healthcare Facilities - Hospitals
- Healthcare Facilities - Post Acute Care
- Healthcare IT
- Managed Care
- PBM/Drug Retail
Research is provided by FBR Capital Markets & Co.(FBRC) Research department, which is independent from the Investment Banking department of FBRC and has the sole authority to determine which companies receive research coverage and the recommendation contained in the coverage. In the normal course of its business, FBRC seeks to perform investment banking and other fee generating services for companies that are the subject of FBRC research reports. Research analysts are eligible to receive bonus compensation that is based on FBRC’s overall operating revenues, including revenues generated by FBRC’s Investment Banking department. Specific information is contained in each research report concerning FBRC’s relationship with the company that is the subject of the report.
FBR believes that the independence and integrity of our Research team are paramount to our mission. FBR Research is completely independent from FBR Investment Banking.